Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Hyperangulated vs. Macintosh Style Blades for Intubation in Obstetric Patients (ANGLED)

HyperANGulated Versus Macintosh styLE blaDes for INtubation in OBstetric Patients: a Cluster Randomized Feasibility Study

Cesarean section under general anesthesia requires intubation (insertion of a tube through the mouth into the breathing pipe to support breathing during the surgery). A device called a video laryngoscope is used, which has a smooth, curved, or less curved component called 'a blade' that helps the doctor gently see the voice box and guide the breathing tube safely into place during anesthesia; it is not a sharp tool blade.

There are two types of video laryngoscopes blades: a Macintosh- style blade with a gentle curve, approximately 90 degrees) and a hyperangulated blade (with a more pronounced curve).

Although video laryngoscopes are safe and both types have been used for around 20 years, it is not known whether one type works better that the other in patients undergoing cesarean delivery under general anesthesia. Because general anesthesia is used in only a small proportion (about 5%) of all cesarean deliveries, research in this area is limited.

The main purpose of the study is to assess if a study comparing these two types of blades in the obstetric population is feasible. This is also known as a feasibility study, which aims to test the study plan and determine whether enough participants will join a larger study and accept the study procedures. The results will be used as a guide for a larger study.

Studienübersicht

Detaillierte Beschreibung

Study design and setting.

This will be a single-site, prospective feasibility study conducted within the Department of Anesthesia and Pain management, Mount Sinai Hospital, Toronto, a high-volume tertiary obstetric centre with established expertise in obstetric anesthesia and airway research.

Intervention and Cluster Assignment

Because individual randomization immediately before induction is often impractical in obstetric emergencies, blade assignment will occur by randomized time-based clusters. Randomization will occur in 4 clusters of 4 months each, separated by one-month washout periods. Four consecutive four-month periods will be randomly assigned to use either a hyperangulated or Macintosh-style blade as the default for the first intubation attempt. Clinicians may deviate from the assigned blade for patient safety. The time-block design minimizes contamination associated with rapid decision-making in obstetric emergencies and aligns with real-world workflow on labour and delivery units.

Randomization

Time-block cluster allocation will be generated by a study statistician who is not involved in clinical care, participant enrollment, or study implementation. The allocation schedule will be finalized prior to study initiation and maintained without modification.

Data Collection

A trained research assistant will extract patient demographic and perioperative data from the electronic medical record and confirm key airway variables with the attending anesthesiologist within 72 hours of Cesarean delivery (CD). Patients will be contacted by telephone on postoperative day 3 to assess airway-related morbidity, including minor oral or dental injuries (lacerations of the lips, teeth, tongue, or oral mucosa) and postoperative sore throat.

Outcomes

The primary feasibility outcomes are patient enrollment, intervention adherence, and data completeness .

Each feasibility outcome will be assessed against its predefined threshold to determine whether to proceed to a full-scale randomized controlled trial (RCT), proceed with protocol modifications, or discontinue the study if feasibility cannot be achieved despite modifications. Recruitment strategies will be adapted if enrollment falls below two patients per week for several consecutive weeks. Feasibility will be interpreted using a green/yellow/red framework. Outcomes meeting green thresholds will be considered feasible (>80%); outcomes meeting yellow thresholds will prompt protocol modification (60-79%); and outcomes meeting red thresholds will be considered not feasible (<60%). Secondary exploratory outcomes include first-attempt intubation success, number of intubation attempts, need for rescue airway techniques, and airway-related complications.

Potential risks associated:

This study poses minimal risk to participants, as it compares two standard-of-care video-laryngoscope blades used by experienced clinicians, with no restriction on clinical judgment or rescue airway management. Both hyperangulated and Macintosh-style video-laryngoscope blades are widely used, approved devices and are part of standard clinical practice at Mount Sinai Hospital. No experimental devices or techniques are being introduced. The choice of blade does not expose participants to risks beyond those already inherent to general anesthesia (GA) and tracheal intubation for cesarean delivery.

Sample Size

A pragmatic sample of 100 participants will be enrolled over 19 months. This sample is sufficient to estimate feasibility parameters with acceptable precision but is not powered to detect clinical superiority.

Statistical Analysis

Feasibility outcomes will be summarized descriptively using proportions and 95% confidence intervals and evaluated using the pre-specified green/yellow/red framework to guide progression to a multicentre RCT. Descriptive statistics will be used to summarize patient characteristics and secondary outcomes. Categorical variables will be summarized as frequencies and percentages; continuous variables as means with standard deviation.

Significance/Importance

By establishing feasibility for a definitive multicentre RCT, this study represents a critical step toward optimizing airway management during CD under general anesthesia. Ultimately, this work has the potential to improve first-attempt intubation success, reduce airway-related complications, and enhance maternal and fetal safety nationwide.

Studientyp

Interventionell

Einschreibung (Geschätzt)

100

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

    • Ontario
      • Toronto, Ontario, Kanada, M5G 1X5
        • Mount Sinai Hospital
        • Kontakt:
        • Hauptermittler:
          • Fabricio Zasso, MD

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Kind
  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Nein

Beschreibung

Inclusion Criteria:

1. Pregnant patients undergoing emergency or urgent cesarean delivery under general anesthesia requiring tracheal intubation.

Exclusion Criteria:

  1. No tracheal intubation performed and (ii) patient refusal of consent.
  2. Patients not receiving general anesthesia.
  3. Patients that previously participated in the study.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Aktiver Komparator: Macintosh style blade
Study patients in this arm will be intubated using a Macintosh style blade
Macintosh- style blade with a gentle curve, approximately 90 degrees
Aktiver Komparator: Hyperangulated blade
Study patients in this arm will be intubated using a Hyperangulated style blade
hyperangulated blade (with a more pronounced curve

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Patient Enrollment
Zeitfenster: 3 days
Percentage of eligible cesarean deliveries under general anesthesia in which patients are recruited and consented
3 days
Intervention Adherence
Zeitfenster: 3 days
Percentage of cases in which the assigned time-block blade was used for the first intubation attempt, with documentation of crossovers and reasons
3 days
Data Completeness
Zeitfenster: 3 days
Percentage of patients with complete data on key airway and perioperative outcomes including postoperatively 3-day follow-up data.
3 days

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

15. Juni 2026

Primärer Abschluss (Geschätzt)

31. Januar 2028

Studienabschluss (Geschätzt)

30. Juni 2028

Studienanmeldedaten

Zuerst eingereicht

15. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

19. Juni 2026

Zuerst gepostet (Tatsächlich)

24. Juni 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

24. Juni 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

19. Juni 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

This is a feasibility study

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Intubation

Klinische Studien zur Macintosh Style Blade

3
Abonnieren